shares of GLAND equivalent to 50.43% of total issued and paid-up shares, for THB 10,162 mn, or at THB 3.10 per share, from a group of major shareholders in GLAND. • Subsequently, CPN Pattaya made a tender
. Top 10 Major Shareholders(@24 Mar 2022) Share % 1. บริษัท BTS GROUP HOLDINGS PLC. 2,033,425,452 36.22 2. บริษัท Thai NVDR Company Limited 404,917,544 7.21 3. SOUTH EAST ASIA UK (TYPE C) NOMINEES LIMITED
2018 MD&A 5 o Avgol enhances IVL's HVA portfolio and market share in the hygiene segment and as the leading producer in Russia and India. o Kordarna (completed 30 Oct, 2018) - propels IVL to a leading
consolidate financial statement as follows: • Income from GLANDRT leasehold asset divestment amount THB 270 mn was recognized in share of profit from associated companies • GLANDRT dissolve expense amount THB
) 8,986 10,171 (1,185) (11.65) 9,428 (442) (4.68) Basic Earnings per Share (Baht) 3.75 4.25 (0.50) (11.65) 3.94 (0.19) (4.68) When compared to the same quarter of the previous year, a decrease of Baht 442
of Thailand. The company has informed the Stock Exchange of Thailand (SET) to make a tender offer for GLOW’s remaining stock of 4.75% at the offering price of 90.8136 Baht per share, in which the
allocating 1,321,428,567 ordinary shares at the price of 56 baht per share. At present, the company has a total ordinary shares of 2,819,729,367 shares with the par value of Baht 10 per share and have changed
$819 million, up 33% YoY Earnings Per Share of THB 4.61, +16% YoY Operating Cash Flow of $1.0 billion 2019 Earnings Guidance reaffirmed Indorama Ventures 2018 MD&A 2 2018 Summary Financials Table 1
คำจำกัดความ / คำนิยาม : รายละเอียดโครงการจัดการ กองทุนเปิด ทสิโก้ ไบโอเทคโนโลย ีเฮลธ์แคร์ รายละเอียดโครงการจัดการกองทุนเปิด ทิสโก้ ไบโอเทคโนโลย ีเฮลธแ์คร ์ 1 สารบัญ ค าจ ากัดความ / ค านิยาม : ....................................................................................................................................................................... 1 1. ชื่อ ประเภท และอายุของโครงการจัดการกองทุนรวม : ...........................................................................................